by Steve Driskill | Jul 7, 2014 | [sub] specification, Estoppel / Disclaimer
A statement directly or indirectly incorporated into the specification that the presence of a particular feature is “universal to all the embodiments” or is “an essential element among all embodiments or connotations of the invention” constitutes a clear and...
by Steve Driskill | Jul 1, 2014 | [sub] written description, Adequate Disclosure
Absent any structural features common to the members of a claimed genus, the specification must disclose representative species that are diverse across the breadth of the claimed genus in order to satisfy the written description requirement. “[A]nalogizing the genus...
by Steve Driskill | Jun 30, 2014 | [sub] offer for sale, Prior Art
An offer for sale of the necessary components of the claimed invention triggers an on-sale bar even if the components require some assembly in order for the claimed invention to be put into operation. “The law only requires that the invention be ‘ready for...
by Steve Driskill | Jun 27, 2014 | [sub] prosecution history, Estoppel / Disclaimer
This case reaffirms Pfizer v. Ranbaxy that “statements made during prosecution of [a] later, unrelated [] patent cannot be used to interpret claims of [another] patent.” Further, because prosecution focuses on “what [a reference] discloses” whereas claim construction...
by Steve Driskill | Jun 27, 2014 | [sub] specification, Estoppel / Disclaimer
Use of open-ended terms such as “including” does not “trump[] consideration of the specification and prosecution history and displace application of standard claim construction principles.” To the contrary, “it is well-established that claim terms must be construed in...